Immunotherapy with haplo-identical KIR-ligand mismatched natural killer cells in the setting of autologous transplantation.

被引：0
|
作者：
Szmania, SM [1 ]
Smith, S [1 ]
Bennett, G [1 ]
Batchu, RB [1 ]
Barlogie, B [1 ]
Cottler-Fox, MH [1 ]
Tricot, G [1 ]
van Rhee, F [1 ]
机构：
[1] Univ Arkansas Med Sci, Myeloma Inst Res & Treatment, Little Rock, AR 72205 USA
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5327
引用
下载
收藏
页码：399B / 399B
页数：1
相关论文
共 40 条
  • [1] Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation
    Shi, Jumei
    Tricot, Guido
    Szmania, Susann
    Rosen, Nancy
    Garg, Tarun K.
    Malaviarachchi, Priyangi A.
    Moreno, Amberly
    DuPont, Bo
    Hsu, Katharine C.
    Baxter-Lowe, Lee Ann
    Cottler-Fox, Michele
    Shaughnessy, John D.
    Barlogie, Bart
    van Rhee, Frits
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 143 (05) : 641 - 653
  • [2] Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation
    Ruggeri, L.
    Mancusi, A.
    Burchielli, E.
    Aversa, F.
    Martelli, M. F.
    Velardi, A.
    CYTOTHERAPY, 2006, 8 (06) : 554 - 558
  • [3] Donor activating KIR genes and survival after haplo-identical hematopoietic transplantation.
    Mancusi, A
    Ruggeri, L
    McQueen, K
    Perruccio, K
    Aversa, F
    Martelli, MF
    Parham, P
    Velardi, A
    BLOOD, 2004, 104 (11) : 610A - 610A
  • [4] Reconstitution of KIR-expressing natural killer cells and survival after haplo-identical stem cell transplantation for acute myeloblastic leukaemia
    Stern, M.
    Ruggeri, L.
    de Angelis, C.
    Mancusi, A.
    Velardi, A.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S201 - S201
  • [5] Temporary remission of lung metastases of an osteosarcoma demonstrated by HLA antibody staining of infiltrating T-lymphocytes of the mother following KIR-ligand mismatched haplo-identical stem cell transplantation
    Schwinger, W.
    Sovinz, P.
    Beham-Schmid, C.
    Lackner, H.
    Benesch, M.
    Strenger, V.
    Schmidt, S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S381 - S381
  • [6] Alloreactive natural killer cells boost adaptive immunity to infections after haplo-identical haematopoietic transplantation
    Ruggeri, L.
    Burchielli, E.
    Hafen, K.
    Perruccio, K.
    Capanni, M.
    Stern, M.
    Aversa, F.
    Martelli, M. F.
    Hollander, G.
    Velardi, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S53 - S54
  • [7] Megadose of activated natural killer cells using KIR epitope incompatibility for pediatric patients after haplo-identical transplantation in leukemic blast persistence
    Koehl, U
    Esser, R
    Zimmermann, SY
    Grüttner, HP
    Sörensen, J
    Bartling, T
    Martin, H
    Lang, P
    Seidl, C
    Tonn, T
    Seifried, E
    Klingebiel, T
    Schwabe, D
    BONE MARROW TRANSPLANTATION, 2003, 31 : S235 - S236
  • [8] KIR-LIGAND mismatched natural killer cells effectively kill primary myeloma and myeloma cell lines.
    van Rhee, F
    Szmania, SM
    Shi, JM
    Cottler-Fox, M
    Dyniewski, JW
    Tricot, GJ
    BLOOD, 2004, 104 (11) : 672A - 673A
  • [9] Irradiated lymphokine-activated killer cells: a safe tool for immunotherapy after haplo-identical stem cell transplantation
    Shapira, M. Y.
    Resnick, I. B.
    Or, R.
    Morecki, S.
    Gelfand, Y.
    Eizik, O.
    Aker, M.
    Bitan, M.
    Zilberman, I.
    Gesundheit, B.
    Samuel, S.
    Dray, L.
    Ackerstein, A.
    Slavin, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S221 - S221
  • [10] Adoptive immunotherapy with haploidentical KIR-ligand mismatched NK cells for acute myeloblastic leukemia patients
    Lemoli, Roberto. M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2017, 47 : 37 - 37
1234